Skip to Main Content

Paper Details

Pathogenic mutations and overall survival in 3,084 patients with cancer: the Hellenic Cooperative Oncology Group Precision Medicine Initiative.
Oncotarget
2
2020
BRCA1, Cancer, MLL3, Patients, TP53, Tumor, adenocarcinoma, cancer, men, metastatic cancer, non-metastatic tumors, patient, patients, tumor, wild-type genes
Author NameAffiliation
Eleni GiannoulatouVictor Chang Cardiac Research Institute
Eleni GiannoulatouThe University of New South Wales
Jianhua ZhangThe University of Texas MD Anderson Cancer Center
Jianhua ZhangThe University of Texas MD Anderson Cancer Center
Phillip A FutrealThe University of Texas MD Anderson Cancer Center
  • 1 - 5

Datasets